Research In Context
Evidence before this study We searched PubMed without language restrictions using the keywords 'Zika' and 'Africa' for papers published to October 2018. We also checked available 'Situation Report' publications from WHO for evidence of Zika virus (ZIKV) or congenital Zika disease in Africa. ZIKV African lineage has been detected within Africa since the mid 20 th century, yet evidence for spread of the ZIKV Asian lineage within Africa is limited. Two countries in Africa (Cabo Verde and Angola) have reported ZIKV cases that are believed to be caused by a newly introduced Asian lineage virus. Sequence data are critical for confirming and understanding the spread of ZIKV Asian lineage within Africa, but these data are currently limited to a single 193bp fragment of the ZIKV NS1 gene from Angola. In addition, whilst epidemiological data on ZIKV and suspected microcephaly cases have been reported in detail from Cabo Verde, data from Angola are extremely limited.
Added value of this study
We provide a detailed report of detected ZIKV acute cases and suspected microcephaly cases in Angola. We sequence ZIKV genomes from three acutely infected cases. These represent the first three Asian lineage genomes available from Africa, one of which was acquired from a baby with confirmed microcephaly. Analysis of these sequences suggests that ZIKV may have been introduced to Angola between July 2015 and June 2016, after which it likely circulated for at least one year. This provides the first genetic confirmation of autochthonous ZIKV Asian lineage transmission within Africa. We suggest that the virus was more likely introduced to Angola directly from Brazil, rather than from Cabo Verde. Our analyses from Angola, only the second African country to report presence of the Asian virus lineage, therefore improve our understanding of the extent and clinical impact of ZIKV Asian lineage in the continent.
Implications of all the available evidence
The circulation of ZIKV Asian lineage within parts of sub-Saharan Africa is concerning given the potential for continued viral spread across much of the continent. Available evidence suggests that ZIKV has circulated and caused cases of microcephaly in Cabo Verde and in Angola. Detecting additional ZIKV transmission using only clinical data on suspected microcephaly or clusters of mild illness may be challenging in countries where systems for reporting birth defects are limited and infectious disease burden is high. Further spread of the ZIKV Asian lineage would likely not be detected unless molecular surveillance systems for ZIKV are implemented to routinely monitor ZIKV transmission in Africa. Implementation of such a surveillance system is especially important in countries that are linked by high human mobility to areas that have experienced recent or ongoing outbreaks of ZIKV.
Abstract

Background
Zika virus (ZIKV) infections and suspected microcephaly cases have been recently reported in Angola, but no data are available on the origins, epidemiology, and diversity of the virus.
Methods
Serum samples from 54 suspected ZIKV cases, 76 suspected microcephaly cases, and 24 mothers of infants with suspected microcephaly were received by the Angolan Ministry of Health. Computed tomographic brain imaging and serological assays (PRNT) were conducted on one microcephalic infant. All sera were tested for ZIKV by RT-qPCR. 349 samples from HIV+ patients and 336 samples from patients suspected of chikungunya virus or dengue virus infection were also tested. Portable sequencing was used to generate Angolan ZIKV genome sequences, including from a ZIKV+ neonate with microcephaly born in Portugal to an Angolan resident. Genetic and mobility data were analysed to investigate the date of introduction and geographic origin of ZIKV in Angola.
Findings
Four autochthonous cases were ZIKV positive via RT-qPCR, with all positive samples collected between December 2016 and June 2017. Viral genomes were generated for two of these cases, and from the neonate with microcephaly identified in Portugal. Genetic analyses and other data indicate that ZIKV was introduced to Angola from Brazil between July 2015 and June 2016. This introduction likely initiated local ZIKV circulation in Angola that continued until June 2017. The scanned microcephaly case showed brain abnormalities consistent with congenital Zika syndrome and serological evidence for maternal ZIKV infection.
Interpretation
Our analyses confirm the autochthonous transmission of the ZIKV Asian lineage in continental Africa. Conducting ZIKV surveillance throughout Africa is critical in the light of presented evidence for autochthonous ZIKV transmission in Angola, and associated microcephaly cases.
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Background
Zika virus (ZIKV) is an RNA virus of the Flavivirus genus that is primarily transmitted by Aedes sp. mosquitos. ZIKV is classified into two distinct lineages, the African and the Asian genotypes. Serological studies suggest that ZIKV may be widespread across Africa, 1 yet the interpretation of serological assays is challenging due to extensive cross-reactivity among related flaviviruses. 2 Prior to 2007, ZIKV was identified in only 14 human cases in Africa and Asia 3 and infection was thought to cause only mild symptoms, including fever, headache and rash. 1 However, since 2013, the Asian genotype of ZIKV spread to locations in the Pacific and the Americas, resulting in > 800,000 suspected and confirmed cases of Zika virus disease. 4 The discovery that ZIKV infection during pregnancy can cause severe birth defects and other adverse outcomes, 2 led to a research response that, to date, has been focused largely on the Americas.
Hundreds of millions of people in sub-Saharan Africa live in areas thought to be suitable for ZIKV transmission. 5 Despite evidence of past transmission in Africa of the African genotype of ZIKV, 3 there is a lack of data on recent ZIKV transmission from the continent. Since 2015, three African countries (Guinea-Bissau, Cabo Verde and Angola) have reported suspected human cases of ZIKV and clusters of suspected microcephaly cases. [6] [7] [8] [9] Understanding these ZIKV outbreaks is critical for safeguarding public health in Africa and elsewhere.
Obtaining accurate ZIKV surveillance data is challenging because most cases are asymptomatic, symptoms are mild and non-specific, and infections are frequently misclassified. 2 In the absence of complete surveillance data, virus genome sequences have proven important for investigating ZIKV transmission. 10 The current lack of ZIKV genomes from Africa hinders our understanding of the re-emergence of ZIKV in the continent.
Here, we provide the first comprehensive study of the recent ZIKV outbreak in Angola. We report and analyse confirmed ZIKV infected cases and suspected microcephaly cases. Computed tomographic (CT) imaging of one infant confirms the presence of brain abnormalities consistent with congenital Zika syndrome. The mother of this infant was serologically positive for ZIKV infection. We tested available serum samples for ZIKV and used portable sequencing technology to generate three Asian lineage ZIKV genome sequences from individuals infected in Angola, including one individual born with microcephaly. 11 Phylogenetic analyses reconstruct the timings and geographic origin of the Angolan ZIKV outbreak. We corroborate our conclusions using multiple data sources, including the climatic suitability of the Aedes mosquito vector, international data on ZIKV incidence and airline passenger numbers. Our study is the first detailed analysis of the introduction to and circulation of ZIKV Asian lineage in Africa.
Materials and Methods
Zika virus surveillance and testing
The Ministry of Health of Angola conducted diagnostic testing of suspected cases of acute ZIKV infection at the Instituto Nacional de Investigação em Saúde (INIS) since late December 2016. Between late December 2016 and November 2018, 54 serum samples were collected from patients following clinical examination. Viral RNA was extracted from these samples using QiaAmp Viral RNA Mini Kits. RT-qPCR testing for the presence of ZIKV, chikungunya virus (CHIKV) and dengue virus (DENV) RNA was conducted using CDC Trioplex kits 12 or Bio-Manguinhos (Fiocruz) ZDC RT-qPCR kits on an Applied Biosystems 7500 Fast machine.
On 1 st January 2018, it became mandatory for health providers in Angola to notify the Angolan Direcção Nacional de Saúde Pública (DNSP) of infants with suspected microcephaly (additional Supplementary Materials and Methods for case identification details). In total, 76 samples were received from infants between January 2017 and November 2018, with a median time of sample collection of 24 days after birth (mean 65 days, range 0-315 days) ( Figure S1 ). Serum samples from 24 mothers who gave birth to infants with suspected microcephaly were also collected. All sera were tested by PCR as described above. Serological testing for toxoplasmosis, rubella and cytomegalovirus (ToRC pathogens) was conducted on eight serum samples from infants with suspected microcephaly using the ViDAS ToRC panel.
An additional 685 serum samples were investigated for ZIKV. Approximately half (n=336) were collected between January and October 2018 from patients with suspected DENV or CHIKV acute infections. These samples were PCR tested for DENV, CHIKV and ZIKV as part of routine diagnosis. The remaining 349 samples were collected between April and November 2017 by the Instituto Nacional de Luta Contra SIDA as part of a separate study investigating antiviral drug resistance among HIV+ patients in Luanda. These samples were retrospectively tested for ZIKV only, to improve the chance of detecting ZIKV cases.
Patients provided written consent forms agreeing that samples could be used for research purposes. Residual samples from Angola were used for viral genomic sequencing with the approval of the National Ethical Committee, Ministry of Health, Angola.
Brain imaging of Angolan infant with microcephaly
CT imaging was conducted on one female child who was born in early August 2017 with suspected microcephaly. The child was born in Angola but diagnosed later at the Microcephaly Reference Centre IPESQ (Campina Grande, Brazil), following travel from Angola to Brazil in early November 2018. Plasma samples were taken from both the mother and child on 30 th November 2018 and tested for ZIKV and DENV infection using EuroImmun IgG ELISAs. Plaque reduction neutralisation tests (PRNT) were performed using standard protocols (Supplementary Materials and Methods) to quantitate neutralising antibodies against ZIKV for both the mother and the child. CT scans were conducted to assess whether the child's neurological damage was consistent with congenital Zika syndrome. CT imaging was performed with a 64-section CT scanner (Philips Brilliance).
ZIKV genome sequencing
Sequencing of the ZIKV genome coding regions was attempted using an Oxford Nanopore (ONT) MinION device following previously published protocols. 13 Virus genome sequencing of RT-qPCR+ samples was attempted at INIS (Luanda, Angola). Generation of consensus sequences was undertaken using a previously published and validated bioinformatics pipeline (Supplementary Materials and Methods). 13 Whilst investigations in Angola were underway, ZIKV RNA was detected in the urine of a neonate with microcephaly born in Portugal in November 2017 to a resident of Angola. Details of this case, a short (193 nt) fragment of the ZIKV NS1 gene from the neonate, and ethical permissions are described elsewhere. 11 Virus genome sequencing of that strain was attempted using the methods described above, at the Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal.
Phylogenetic analyses
The new ZIKV genomic sequences were aligned with 390 other ZIKV genomes publicly available from GenBank using Muscle. 14 Maximum likelihood phylogenies were estimated using RAxML v8.2.11, 15 and molecular clock phylogenies were generated in BEAST v1.10.3 16 (see Supplementary Materials and Methods for further details).
Origins of Angolan ZIKV outbreak
To corroborate the results of our genomic analyses, we investigated countries that could have exported ZIKV to Angola using additional data sources. Specifically, two factors were considered here as contributing to a high risk of ZIKV introduction to Angola: (i) countries with a high local incidence of ZIKV, and (ii) countries with high numbers of air passengers travelling to Angola. The monthly number of passengers to Angola from countries reporting ZIKV was estimated using worldwide ticket sales data from the International Air Transport Association during 2015-2017. 17 The average incidence rate per person per week in each country was estimated from surveillance data on the number of suspected and confirmed cases of ZIKV per epidemiological week. 7, 18 See Supplementary Materials and Methods for details.
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Results
Confirmed autochthonous ZIKV transmission in Angola
We collated evidence of ZIKV in Angolan residents or in travellers returning from Angola (Figure 1) . ZIKV infection was first detected by seroneutralisation assay in a traveller returning from Angola in September 2016. 19 The presence of ZIKV in Angola during 2016 and 2017 was also indicated by the detection of ZIKV in two travellers; one to Portugal 11 and another returning to Taiwan 20 (Figure 1) . Whilst suspected cases were reported across Angola (Figure 2) , all confirmed cases were residents of (or had travel history involving) Luanda or the neighbouring province of Bengo (Figures 1 & 2) . 
Microcephaly in Angola
Suspected microcephaly cases identified in Angola before November 2018 are shown in Figure 2 . The number of neonates identified with suspected microcephaly peaks around November 2017, and subsequently declines ( Figure  2B) . The peak occurs several months after several PCR-confirmed ZIKV acute cases were detected in Angola (Figure 2B, red dots) . However, the temporal and geographical distributions of suspected microcephaly and ZIKV cases are difficult to interpret with confidence because the total number of reported cases is low, the consistency of case detection and reporting are likely highly variable, and the intensity of surveillance efforts has changed over time (Supplementary Materials and Methods).
Of the 76 samples from infants with suspected microcephaly, none were positive for ZIKV by RT-qPCR. No maternal samples (n=24) tested PCR positive for ZIKV. This is not surprising, given that most infant samples were collected long after ZIKV is expected to be cleared from blood fluids 21 (median time between birth and sample collection was 24 days, Figure S1) , and because ZIKV infection may have occurred months prior to birth. Only 8 samples from infants with suspected microcephaly could be tested for infection with ToRC pathogens; none showed evidence of recent ToRC infection.
In addition to the suspected microcephaly cases reported to INIS, one Angolan microcephaly case was identified in Brazil. The 21 year-old mother of this child was a long-term resident of Moxico province in Angola, but travelled to Luanda during the second and third months of pregnancy and reports a rash during this visit (week 10 of pregnancy; January 2017). Confirmed ZIKV cases were identified in Luanda and Bengo province at this time (Figure 1) . The neonate was delivered in early August 2017 in Angola, coincident with the rise in suspected microcephaly cases (Figure 2) . CT scans of the child's brain conducted at 15 months confirmed microcephaly through reduced cerebral volume, and showed abnormalities consistent with congenital Zika syndrome observed in Brazil and elsewhere 22 (Figure 3) . When tested serologically, the child was IgG negative for both DENV and ZIKV by ELISA, and weakly positive for neutralising antibody response by PRNT (PRNT90 titre = 40). This result does not exclude intrauterine ZIKV exposure, as the child was 15 months -old at testing (see Materials and Methods) and maternally acquired IgG antibodies are present for only 6-12 months after birth. 23 The mother was strongly IgG positive for ZIKV by ELISA, with a weaker DENV IgG response. PRNT assays confirmed the strong neutralising antibody response in the mother, with a PRNT90 titre of 1280. This result strongly suggests that the mother had been previously infected with ZIKV. 
Sequencing and genetic analysis of ZIKV
We sequenced three virus genomes from patients infected with ZIKV in Angola. Table S1 provides sequencing statistics and GenBank accession numbers. The three Angolan ZIKV sequences differ from each other at 34 nucleotide sites. Three of these variable sites cause amino acid changes: Y135H (in sample Z3), Y3038H and D3344E (both in sample PoHuZV_634939, isolated from a microcephaly patient 11 ). Neither of the two amino acid changes observed in strain PoHuZV_634939 are seen in either of the two most closely related ZIKV genomes obtained from infants born with microcephaly in Brazil (GenBank accession numbers KU729217, KU527068).
Maximum likelihood (ML) phylogenies indicate that all three ZIKV strains from Angola form a single, well-supported monophyletic clade within the ZIKV Asian genotype lineage currently circulating in the Americas (Figure S3 ; bootstrap score = 0·96). Thus the ZIKV outbreak in Angola likely resulted from a single successful introduction of the virus, followed by autochthonous transmission within Angola. We used a Bayesian phylogenetic framework to investigate when and from where ZIKV was introduced to Angola. Our analyses indicate that ZIKV was likely introduced to Angola from Brazil (Figure 4) , possibly from the southeast of Brazil, where the most closely related virus to the Angola ZIKV clade was sampled (accession number KY559016; posterior probability = 0·99). The estimated date of the most recent common ancestor of the ZIKV Angolan sequences is June 2016 (Bayesian 95% credible interval, January 2016-October 2016) (Figure 4) . The date of divergence of the Angolan ZIKV cluster from the most closely related Brazilian ZIKV sequence is July 2015 (February 2015-February 2016) (Figure 4) . These estimates therefore indicate that ZIKV was introduced to Angola from Brazil between July 2015 and June 2016. Thus ZIKV may have circulated in Angola for 3 to 14 months before being identified for the first time, via a traveller returning from Angola. 19 
Evaluation of the outbreak's geographic origin
A ZIKV outbreak was reported in Cabo Verde during 2015-2016, from which no genetic sequence data are currently available. 7 The absence of ZIKV genetic data from key locations, such as Cabo Verde (Figure 5) , means that we cannot unambiguously infer the geographic origin of the Angolan ZIKV outbreak using phylogenetic analysis alone. We therefore analysed global ZIKV incidence and human mobility data to predict the likely source of ZIKV in Angola. Vertical bars show the 25% and 75% quartiles of monthly passenger numbers. The horizontal axis shows the median weekly number of suspected or confirmed ZIKV cases per person during the same period. Horizontal bars show the quartiles of ZIKV case numbers. Point diameters are proportional to the total number of genomic sequences currently available from each country. The 11 countries shown include all those with the with the seven highest median passenger numbers and the seven highest number of ZIKV cases per person. Colour indicate geographic region (red: Africa, green: Central America, purple: South America, blue: USA, orange: Caribbean).
We found that 80% of all air passengers who travelled to Angola from countries reporting ZIKV began their journey in Brazil, whilst only 0·15% originated from Cabo Verde. The number of passengers that travelled to Angola per month was therefore over 500 times higher from Brazil than from Cabo Verde (Figure 5) . Crucially, Brazil is the only country that exhibits both high connectivity with Angola via air travel and a high average rate of ZIKV cases per person (Figure 5 , top right). Further, the climatic suitability for Aedes-borne viral transmission was more closely synchronised between Angola and Brazil than Angola and Cabo Verde (Figure S4) . Introduction of ZIKV to a new location is most likely to be successful when environmental suitability for the mosquito vector is high in both the source and destination locations. Thus, multiple lines of evidence (ZIKV incidence, mobility data, and virus phylogenetic analysis) support the hypothesis that ZIKV was introduced directly to Angola from Brazil.
Discussion
Here, we characterise the first known outbreak of Asian lineage ZIKV in continental Africa. We tested 54 suspected cases of acute ZIKV infection and 76 suspected microcephaly cases sampled across Angola by RT-qPCR. Three suspected cases of acute ZIKV infection, all notified between December 2016 and May 2017, were ZIKV positive. A further ZIKV+ case was detected in a cohort of 349 HIV+ patients sampled in Luanda in June 2017. To understand the origins of the Angolan outbreak, we sequenced ZIKV genomes from two autochthonous cases and a confirmed microcephalic neonate, born in Portugal to a resident of Luanda. These represent the first ZIKV Asian lineage genomes reported from Africa, and the first genome from a ZIKV associated microcephaly case in Africa.
We analysed suspected microcephaly cases reported to INIS during 2017-2018. The fact that we found no ZIKV-positive cases among 76 suspected microcephaly cases does not indicate the virus was absent from this group, because the samples were collected long after birth, at which point ZIKV viremia is expected to have declined to undetectable levels in blood fluids. 21 To maximise ZIKV detection sensitivity in suspected microcephaly cases, sera and urine samples for RT-qPCR should be collected as soon as possible after birth, and ideally within the first few days. 24 Systems for the detection and reporting of birth defects are limited in sub-Saharan Africa, so the spatiotemporal distribution of suspected cases must be interpreted cautiously. In addition to the 76 suspected microcephaly cases identified in Angola, two cases of microcephaly acquired in Angola have been confirmed in other countries. Both cases (one of which is clinically reported here) have strong serological evidence for maternal ZIKV exposure and brain abnormalities consistent with congenital Zika syndrome. 11, 22 Further, both confirmed microcephaly cases were born a few months after the date of sampling of PCR-confirmed ZIKV infections in Angola. A time lag of ~5 months between ZIKV incidence and occurrence of microcephaly cases has been observed elsewhere. 25 We show here that ZIKV detected in one these confirmed microcephaly cases 11 belongs to a virus lineage originating from the Americas, and which likely circulated in Angola for at least 12 months. Continued identification of confirmed cases of acute ZIKV infection and ZIKV-associated microcephaly in Angola remains a priority to understand the clinical consequences of ZIKV in Africa.
Phylogenetic analysis shows that the three Angolan ZIKV genomes form a single clade whose common ancestor dates to June 2016 or earlier. Successful introductions of ZIKV to new regions often occur during seasons of peak climatic suitability for Aedes-borne transmission. 10, 26 Under this scenario, ZIKV would most likely have entered Angola between November 2015 and April 2016 ( Figure S4) . Detection of a single ZIKV outbreak clade in Angola is compatible with two scenarios, (i) a single successful introduction that initiated local ZIKV transmission in Angola , continuing until at least June 2017 or (ii) recurrent but later introduction to Angola of viruses belonging to a specific ZIKV lineage present in Brazil. The latter is much less likely, as it is improbable that three or more independent introductions of ZIKV to Angola belonged to just one of the many different lineages of ZIKV that co-circulated in Brazil. 10 If the former scenario is correct, then ZIKV may have circulated undetected in Angola for at least 3 months before a case was first detected in a returning traveller, 19 and at least 6 months before a local case was detected (Figure 1) . Similar or longer periods of cryptic ZIKV transmission have been reported in the Americas 10 and attributed in part to the difficulties in identifying clinical cases when infections are asymptomatic or mildly symptomatic. 27 Retrospective screening of stored samples and identification of young children with suspected microcephaly, will help to determine the magnitude and duration of undetected ZIKV transmission in Angola since 2015.
We conclude that ZIKV was introduced to Angola from Brazil. This is consistent with previous predictions that, given the presence of ZIKV in Brazil, Angola is the African country most at-risk of importing the virus. 28 Transmission of mosquitoborne viruses between these two countries was demonstrated previously by the spread of CHIKV East-Central-South African genotype (ECSA) from Angola to Brazil in June 2014. 29 The introduction of ZIKV to Angola underscores the need to coordinate viral surveillance strategies across countries that share high human interconnectivity and similar vector-borne transmission potential, regardless of the transnational distance involved. Detecting ZIKV transmission using only clinical data on clusters of mild illness or suspected microcephaly would be extremely difficult in this setting. Molecular surveillance systems are therefore needed to monitor further ZIKV spread in Africa, including those countries potentially at risk of ZIKV introduction from Angola. 30 The epidemiology and clinical significance of Asian and African ZIKV lineages in Africa is unclear. Widespread screening of pregnant women for STORCH pathogen infections, sensitive ZIKV antibody-based assays, and follow-up of children born with abnormalities would improve our understanding of the extent and causes of birth defects in Africa. Additional genomic surveillance of other mosquito-borne viruses, such as dengue and Japanese encephalitis virus, is required to inform effective intervention strategies to ameliorate disease burden in Angola. Previously, genomes of emerging viruses have been typically generated in a small number of highly resourced genomic centres, located in wealthy nations. The introduction of low cost, portable sequencing technology to laboratories in Africa heralds an era in which virus genome sequencing is widespread, real-time, and sustainable, with the potential to directly inform public health responses to future emerging outbreaks. and commented on manuscript drafts. NRF and JA led the design and execution of the study, and oversaw all analyses and interpretation. All authors have seen and approved of the final text.
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